Pharmaceutical companies are developing new weight-loss treatments that aim to shed the pounds while preserving muscle mass -- a downside of current drugs. (Reuters via MSN) In a phase Ib trial, ...
CHICAGO – “Lean type 2 diabetes (T2D)” is a diagnosis of exclusion but is also a true entity affecting roughly 10%-20% of people with T2D. That was the message from Kristina Utzschneider, MD, ...
This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice. Conclusions: ...
Hosted on MSN
Fotagliptin Boosts Glycemic Control in Type 2 Diabetes When Added to Metformin, Study Finds
A groundbreaking study has revealed that fotagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, significantly enhances glycemic control in patients with type 2 diabetes (T2D) when combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback